Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Phase Capital is an investment firm that accelerates early-stage tech-bio companies (pre-seed to Series A) at the convergence of technology, biology, and data science. They back founders building next-generation tools that translate biological complexity into technological opportunity, from life-changing therapeutics to scalable, sustainable solutions across industry and society. They partner with technical founders and an extended network of advisors, hosting events like Frontiers 2026 and engaging with major industry conferences.
Parse Score